2022
DOI: 10.1016/j.jaad.2021.09.043
|View full text |Cite
|
Sign up to set email alerts
|

Pseudoangioedema in dermatomyositis patients indicates severe disease and poor prognosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
5

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 5 publications
0
7
0
5
Order By: Relevance
“…3 Published cases support the hypothesis that pseudoangioedema may have a poor prognosis in dermatomyositis patients, requiring assessment of underlying disorders and aggressive management as its development coincides with exacerbations. 24 The diagnosis is confirmed by typical and clinical electromyogram patterns, enzyme increases and muscle biopsies. 4 Management options include intravenous immunoglobulins, rituximab and systemic corticosteroids.…”
Section: Dermatomyositismentioning
confidence: 83%
See 1 more Smart Citation
“…3 Published cases support the hypothesis that pseudoangioedema may have a poor prognosis in dermatomyositis patients, requiring assessment of underlying disorders and aggressive management as its development coincides with exacerbations. 24 The diagnosis is confirmed by typical and clinical electromyogram patterns, enzyme increases and muscle biopsies. 4 Management options include intravenous immunoglobulins, rituximab and systemic corticosteroids.…”
Section: Dermatomyositismentioning
confidence: 83%
“…25 Classically, statininduced necrotizing autoimmune myopathy has not been associated with cutaneous manifestations. 24 However, in recent years cases have been published in which pseudoangioedema developed following the classic heliotrope pattern. 25…”
Section: Statin-induced Autoimmune Necrotizing Myopathymentioning
confidence: 99%
“…Interestingly, Xu et al 7 recently reported that pseudoangioedema, subcutaneous swelling resembling angioedema found in nonurticarial conditions such as drug rash with eosinophilia and systemic symptoms and acute contact dermatitis, 8 in patients with DM portends more severe disease and poorer prognosis. These patients exhibited nonpitting edema with no history of other edema-causing diseases and nonpruritic rashes that failed to respond to antihistamines.…”
Section: Discussionmentioning
confidence: 99%
“…3 Veröffentlichte Fälle stützen die Hypothese, dass das Pseudoangioödem bei Dermatomyositis-Patienten eine schlechte Prognose haben kann und die Erfassung zugrundeliegender Krankheiten sowie aggressive Therapien erfordert, da seine Entwicklung mit Exazerbationen zusammenfällt. 24 Die Diagnose wird durch typische und klinische Elektromyogramm-Muster, Enzymanstiege und Muskelbiopsien bestätigt. 4 Zu den Behandlungsoptionen gehören intravenöse Immunglobuline, Rituximab und systemische Kortikosteroide.…”
Section: Dermatomyositisunclassified